Genepharm Australasia Ltd's Cancer Drugs Approved By Therapeutic Goods Administration

San Francisco, March 9 (By Suvarna Bhatt, BioSpace) – Australian generics company, Genepharm Australasia announces marketing authorization approval from the Therapeutic Goods Administration (TGA) to sell its anti-cancer drugs, Epirubicin and Carboplatin as injectables in Australia. These are two of the leading drugs used in Australian hospitals for the treatment of cancer.